These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B. Am J Obstet Gynecol; 2004 Mar; 190(3):644-53. PubMed ID: 15041994 [Abstract] [Full Text] [Related]
28. Chronic vulvovaginal candidosis: the role of oral treatment. Merkus JM, Van Heusden AM. Br J Clin Pract Suppl; 1990 Sep; 71():81-4. PubMed ID: 1965421 [Abstract] [Full Text] [Related]
29. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, Alberico S. Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459 [Abstract] [Full Text] [Related]